Pot Industry Faces Lukewarm Prospects for U.S. Reform in 2022
A worker walks through the grow room of an Aphria facility in Leamington, Canada.
Photographer: Annie Sakkab/BloombergWelcome to The Dose, Bloomberg’s newsletter about the cannabis and psychedelics industries.
A tectonic shift is taking place as previously underground drugs are thrust into the mainstream. With The Dose, you’ll get a weekly chronicle of the biggest news about the companies and personalities that are shaping this change.